We are trying to develop a policy and work instruction for how to handle patient's own insulin pumps in a perioperative setting and also for patients that are admitted acutely ill and on an insulin pump at home. I would appreciate any information and/or resources that anyone could provide. Do you have standard instructions for when to adjust or turn pump off prior to surgery/procedures? How and when to transition to intermittent sq insulin for inpatient use? Do you allow the use of patient's home continuous glucose monitoring systems? etc. Thanks in advance!

We are trying to develop a policy and work instruction for how to handle patient's own insulin pumps in a perioperative setting and also for patients that are admitted acutely ill and on an insulin pump at home. I would appreciate any information and/or resources that anyone could provide. Do you have standard instructions for when to adjust or turn pump off prior to surgery/procedures? How and when to transition to intermittent sq insulin for inpatient use? Do you allow the use of patient's home continuous glucose monitoring systems? etc. Thanks in advance!

In the past couple of months, our anesthesia team has experienced 3 cases (performed by experienced anesthesiologists) where the spinal block was failed or ineffective. They claim that there has been no issues with the exact same product (Hospira) that is supplied in the spinal kits. And, each failed case has been with bupivacaine that is stocked in the ADC.

This week, we had another case with a different lot number. We've reached out to the manufacturer with the affected lots, and their representatives have stated that there are no quality issues.

Has anyone implemented the new TJC standard for ICU block charting of titration medications in urgent/emergent situations? What were your challenges? What situations are defined in your policy? Are you monitoring to ensure it meets the intent of the standard? Lessons learned?

Hello Colleagues,

We're a little behind in getting USP<800> to lift-off. We are struggling in some areas more than others in getting this over the finish line.

That would be an education plan for disposal and what to do about medical surveillance ( a recommendation but we still wanted to do "something on some level).

If anyone is willing to share their USP <800> Policy, that would be great!

Stericycle is our primary company for disposal but they don't handle our Chemo.

Thanks, n advance.

Hello,

Our organization recently switched from Privigen to Gammagard and we have had an uptick in skin reactions. Has anyone else had any similar reports when utilizing Gammagard?

Thank you!

I am reaching out to see if anyone is able to share their policy for scanning and administering medications in both the Inpatient setting and the Outpatient setting. We are interested in the purpose, bullet points and any clear expectations.

Good Morning All-

Just wondering what sites are using for myomectomy? We have a lot utilization of vasopressin in the OB space. Is anyone seeing a similar trend?

Natalie Zilban, PharmD, MPH
Medication Safety and Pharmacy Officer
3111 Stirling Rd Hollywood, FL 33312
nzilban@mhs.net

Looking for recommendations on whether other institutions are mentioning strength of vial on the label itself?

If 2 different percent strength are being used , e.g as in epidural label we are using bupivacaine 0.25 and 0.5%, is this information shown on the label?

Looking for recommendations on whether other institutions are mentioning strength of vial on the label itself?

If 2 different percent strength are being used , e.g as in epidural label we are using bupivacaine 0.25 and 0.5%, is this information shown on the label?